Journal Options HIV - Volume 3, Issue 3

Course Directors: Joseph J. Eron, Jr., MD, William G. Powderly, MD, Andrew R. Zolopa, MD

Browse Journal Options by Topic

View Collections

Volume 3, Issue 3 Articles

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
MacArthur RD, Novak RM, Peng G, et al.
Lancet. 2006;368:2125-2135.
Capsule Summary | Expert Commentary | Abstract | Slides
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
Flys TS, Donnell D, Mwatha A, et al.
J Infect Dis. 2007;195:711-715.
Capsule Summary | Expert Commentary | Abstract | Slides
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 infection (AIDS Clinical Trials Group Study A5095).
Shikuma CM, Yang Y, Glesby MJ, et al.
J Acquir Immune Defic Syndr. 2007; [Epub ahead of print]
Capsule Summary | Expert Commentary | Abstract | Slides
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.
Fischl MA, Collier AC, Mukherjee AL, et al.
AIDS. 2007;21:325-333.
Capsule Summary | Expert Commentary | Abstract | Slides
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.
Chamie G, Bonacini M, Bangsberg DR, et al.
Clin Infect Dis. 2007;44:577-583.
Capsule Summary | Expert Commentary | Abstract | Slides